Explained: Why Onesource Specialty Pharma and Shaily Engineering stocks were in focus today

Onesource Specialty Pharma and Shaily Engineering Plastics gained as investors bet on India’s role in the global GLP-1 semaglutide supply chain, despite Onesource’s weak Q3 results

Leave a Reply

Your email address will not be published. Required fields are marked *